Samsung Biologics Webinars
-
CLD To Upstream Optimization: Enhancing Biologics Quality, Productivity
4/30/2025
Explore how advanced cell line development and upstream processing strategies optimize both productivity and therapeutic effectiveness, ensuring the development of high-quality biologics.
-
Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights
3/5/2025
Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.
-
Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics
11/6/2024
Unlock the potential of antibody-drug conjugates (ADCs) by exploring our novel payloads, designed for easy access and evaluation, to accelerate your ADC drug development with proven efficacy and safety.
-
Navigating Challenges During Formulation Development
9/11/2024
Gain valuable knowledge on addressing formulation stability, improving product shelf life, and enhancing overall product performance in biopharmaceutical studies.
-
Formulation Considerations For The Development Of High Concentration Biopharmaceuticals
9/11/2024
This session addresses key obstacles—such as opalescence, viscosity, and aggregation—and present real-world case studies on how composition changes during the concentration process can be effectively characterized.
-
Mitigating Early Development Risks With Samsung Biologics DEVELOPICK™ Platform
6/5/2024
This presentation addresses the critical need for high-throughput, reliable analytical development strategies to support expedited Investigational New Drug (IND) applications.
-
Downstream Strategies To Accelerate Preclinical Development Timelines
4/3/2024
As recombinant protein-based products accelerate toward IND, reliable process development methods are critical to meet demand. Review case studies to learn how expedited timelines can be achieved.
-
Enhancing Quality By Employing Cell Line Replacement, Process Optimization
3/19/2024
Explore how the various proprietary platforms and in-house expertise fit together to enable a range of comprehensive options that can be adapted to fit development strategies.
-
All Eyes On mRNA: Addressing Key Insights Into The Next Blockbuster
With ongoing development efforts seeing infinite possibilities for cancers, autoimmune diseases, and genetic diseases, how should the industry apply this early victory into successful mRNA-based therapeutics and vaccines?
-
Key Considerations When Outsourcing An Aseptic Fill/Finish Project To A CMO Partner
This presentation addresses keys to outsourced drug production, including the importance of seeking the right partnerships to help overcome the challenges associated with secure commercial product supply.